Cargando…
A network-biology led computational drug repurposing strategy to prioritize therapeutic options for COVID-19
The alarming pandemic situation of novel Severe Acute Respiratory Syndrome Coronavirus 2 (nSARS-CoV-2) infection, high drug development cost and slow process of drug discovery have made repositioning of existing drugs for therapeutics a popular alternative. It involves the repurposing of existing sa...
Autores principales: | Khurana, Pankaj, Varshney, Rajeev, Gupta, Apoorv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9093055/ https://www.ncbi.nlm.nih.gov/pubmed/35578630 http://dx.doi.org/10.1016/j.heliyon.2022.e09387 |
Ejemplares similares
-
HighAltitudeOmicsDB, an integrated resource for high-altitude associated genes and proteins, networks and semantic-similarities
por: Gupta, Apoorv, et al.
Publicado: (2023) -
Drug mechanism enrichment analysis improves prioritization of therapeutics for repurposing
por: Garana, Belinda B., et al.
Publicado: (2023) -
Drug repurposing using computational methods to identify therapeutic options for COVID-19
por: Mahdian, Soodeh, et al.
Publicado: (2020) -
Systematic integration of biomedical knowledge prioritizes drugs for repurposing
por: Himmelstein, Daniel Scott, et al.
Publicado: (2017) -
Systematically Prioritizing Candidates in Genome-Based Drug Repurposing
por: Challa, Anup P., et al.
Publicado: (2019)